Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Among Today’s Most Volatile Stocks – Down by 1.67%


Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is at $1.18 having a low of $1.16 and high of $1.22. This range of trading classifies the stock as one of the most volatile of the day.

It is trading at $1.18 a tad below $1.21, the 50 day moving average and a great deal lower than the 200 day moving average of $1.92. The 50 day moving average moved down $-0.03 whereas the 200 day average was down by -38.47%.

Short Interest

Investors are more bearish on Ekso Bionics Holdings, Inc. recently if you watch the change in short interest. The firm realized a rise in short interest of 12.63% between August 31, 2017 and September 15, 2017. Short shares grew from 1,769,613 to 1,993,044 over that period. Days to cover decreased -4.0 to 3.0 and the percentage of shorted shares was 0.08% on September 15.

Insider Activity

There has been some buying and selling insider activity on Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) recently. Russ Angold, President, EksoWorks reported the sale of 9,352 shares of EKSO stock. The shares were purchased at an average price of $1.33. Angold now owns $320,964 of the stock according to the SEC filing. Max Scheder-bieschin, CFO acquired $11,300 worth of shares at an average price of $1.13 on Thu the 7th. That brings the CFO’s holdings to $36,579 as reported to the SEC. In the latest earnings report the EPS was $-1.59 and is expected to be $-0.72 for the current year with 25,789,000 shares now outstanding. Analysts expect next quarter’s EPS to be $-0.08 with next year’s EPS projected to be $-0.32.

Company Information

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Asia. The company operates through Engineering Services and Medical segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, stroke, and other lower limb paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a collaborative partnership with Lockheed Martin Corporation to develop products for military applications, as well as a license agreement with OttoBock Healthcare Products Gmbh. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital..